2019

1. Residual vascular risk in diabetes – Will the SPPARM alpha concept hold the key?

   Diabetes and Metabolic Syndrome: Clinical Research and Reviews, Vol. 13, Núm. 4, pp. 2723-2725

2. The selective peroxisome proliferator-activated receptor alpha modulator (SPPARMα) paradigm: Conceptual framework and therapeutic potential

   Cardiovascular Diabetology, Vol. 18, Núm. 1